Back to Medicines

Familial Hypercholesterolaemia

Prescription Medicines Editorial 7 December 2024

Familial hypercholesterolaemia is an inherited condition causing very high cholesterol from birth. It affects roughly one in 250 people, which makes it considerably more common than most people assume, and the large majority remain undiagnosed. Untreated, it causes heart disease decades earlier than usual. Treated, outcomes approach those of the general population - which makes finding it one of the more worthwhile things medicine does.

What it is

A genetic fault affecting the liver's ability to clear LDL cholesterol from the blood - most often in the LDL receptor.

The result is a high LDL level from birth, rather than one developing in middle age through diet and lifestyle.

Because the exposure is lifelong, arteries accumulate damage from childhood, and untreated heart disease appears far earlier.

It is inherited in an autosomal dominant pattern, meaning each first-degree relative of an affected person has a one in two chance of having it. That single fact is what makes family testing so productive.

When to suspect it

Very high cholesterol - substantially above the usual range, and not explained by diet, weight, thyroid problems or other causes.

A family history of early heart disease - a heart attack, angina or sudden cardiac death in a parent, sibling or grandparent at a young age. This is the strongest clue and the one most often not asked about.

A family history of very high cholesterol.

Physical signs, when present: tendon xanthomas - firm swellings in the Achilles tendons or the tendons on the backs of the hands - which are close to specific for the condition; xanthelasma, yellowish deposits around the eyelids; and corneal arcus, a pale ring around the iris, which is significant when it appears before about 45.

The signs are frequently absent, so their absence proves nothing.

If this describes your family, ask for your cholesterol to be checked and for the family history to be recorded.

Risk calculators do not apply

An important technical point with practical consequences.

Tools such as QRISK estimate risk over the next ten years in the general population. They are not valid in familial hypercholesterolaemia, because the lifelong exposure is entirely different.

So a young person with FH may produce a low ten-year risk score while having a very high lifetime risk.

Treatment decisions are therefore made on the diagnosis itself rather than on a calculated score - which is why getting the diagnosis right matters so much.

See understanding your cholesterol numbers.

Diagnosis

Based on cholesterol level, personal and family history, and physical signs, using recognised criteria.

Genetic testing is available and confirms the diagnosis where a causative variant is found - though a negative test does not entirely exclude it.

Specialist referral is recommended for assessment and for family screening.

Cascade testing

The most valuable part, and frequently not done.

Once one person is diagnosed, first-degree relatives are offered testing - parents, siblings and children - and each newly identified person's relatives in turn.

Because each relative has a one in two chance, this finds cases very efficiently.

Testing children is recommended, generally in childhood, since treatment can begin early and the arterial damage is cumulative.

If you have been diagnosed, ask specifically about cascade testing for your family. It is the single most useful thing that follows a diagnosis, and it is the step most often missed.

Treatment

The aim is a substantial reduction in LDL cholesterol, and targets are tighter than for ordinary raised cholesterol.

High-intensity statins are first-line, frequently at higher doses than usual, and are used in children from an appropriate age.

Ezetimibe is commonly added.

Where targets are not reached, PCSK9 inhibitors given by injection, and inclisiran, are available through specialist services.

Lifestyle measures matter but cannot do this alone - the problem is a receptor fault, not diet, and it is important that people are not left feeling the condition is their fault.

See ezetimibe and evolocumab.

Pregnancy

Statins, ezetimibe and PCSK9 inhibitors are stopped before conception and during pregnancy and breastfeeding.

That needs planning in advance rather than discovering, and specialist advice on how long to pause and when to resume.

See getting the right medicine in pregnancy.

Living with it

Treatment is lifelong and the outlook with it is good.

Other risk factors matter more than usual - not smoking, blood pressure control, and weight - because they add to an already elevated baseline.

Keep the diagnosis clearly on your record, tell any new prescriber, and make sure your children know.

Heart UK is the main patient organisation for this condition and is a reliable source of further information.

Related reading: Statins and Muscle Pain: What the Evidence Says, with more on how the main families of medicine work in Medicines.